EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (Under Process) , 

 ISSN 2394-3211

Impact Factor: 4.897

 ICV - 79.57

Abstract

THE ASSOC?AT?ON BETWEEN RHEUMATO?D ARTHR?T?S AND ANKYLOS?NG SPONDYL?T?S W?TH HEPAT?T?S B AND C V?RUSES

Tuba Tülay Koca*, MD., Zuhal ALTAY, Prof. MD., Bekir Durmu?, Doç. MD.

ABSTRACT

Objective: To study the association of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) diseases with HBV and HCV viruses together with etiopathogenesis, concomitance, differential diagnosis and treatment. Materials and Method: The study included 101 RA and 117 AS patients. Two different control groups comprised 113 subjects for the RA group and 94 for the AS group. All patient records were retrospectively reviewed for serological status. Demographic characteristics, duration of disease and treatment regimens were noted. To evaluate disease activity, serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were recorded. HBs Ag, HBs Ab and anti-HCV screening was performed in all patients. Patients positive for HBs Ag were tested for HBe Ag, HBe Ab, HBc Ag, HBc Ab, HBV–DNA parameters. Anti HCV positive patients were tested for HCV-RNA. All positive ratios were compared with the RA, AS and control groups. Results: The mean age was 51.9±12.6 years and 38.4±11.1 years in patients with RA and AS, respectively. HBs Ag prevalence of 1.9% (2/101) was found in the RA group. There was no statistically significant difference in the RA group compared with the control group. Positive results in HBs Ag and/or HBs Ab were assessed as viral contact. HBs Ag and/or HBs Ab positivity prevalence of 37.6% (38/101) was found in the RA group. There was no statistically significant difference in the RA group compared with the control group. Anti HCV prevalence of 0.9% (1/101) was found in the RA group. There was no statistically significant difference in the RA group compared with the control group. HBs Ag prevalence of 6% (7/117) was found in the AS group. There was no statistically significant difference in the AS group compared with the control group. HBs Ag and/or HBs Ab prevalence of 46.1% (54/117) was found in the AS group. There was no statistically significant difference in the AS group compared with the control group. Anti-HCV positivity prevalence of 0.9% (1/117) was found in the AS group. There was no statistically significant difference in the AS group compared with the control group. Conclusion: RA and AS diseases are firmly associated with HBV and HCV viruses in respect of defining etiopathogenesis, concordance, differential diagnosis and treatment regimens. In this study, it was aimed to clarify this association. Further studies are necessary for better understanding.

Keywords: Rheumatoid arthritis, hepatitis B virus, hepatitis C virus, ankylosing spondylitis,


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2018 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR OCTOBER ISSUE PUBLISHED

    OCTOBER 2018 Issue has been successfully launched on 1 October 2018

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 4.161 to 4.897 due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (Under Process)